1Karl Y.Bilimoria,David J.Bentrem,Clifford Y.Ko.et al.Nationa 1 Failure to Operate on Early Stage Pancreatic Cancer.Annals of Surgery,2007;246(2):173-180. 被引量：1
5McElveen TL,Waterman FM,Kim H et al.Factors predicting for urinary incontinence after prostate brachytherapy.Int J Radiat Oncol Biol Phys 2004;59:1395-1404. 被引量：1
6Peschel RE,Colberg J W,Chen Z et al.Iodine 125 versus palladium 103 implants for prostate cancer:clinical outcomes and complications.Cancer J 2004;10:170-174. 被引量：1
7Simpson F,Doig GS.Parenteral vs.enteral nutrition in the critically ill patient:a meta-analysis of trials using the intention to treat principle.Intensive Care Med.2005;31(1):12-23. 被引量：1
2Holm HH,Stroyer I,Hansen H,et al.Ultrasonically guided percutaneous interstitial implantation of iodine 125 seeds in cancer therapy.Br J Radiol,1981,54:665-670. 被引量：1
3Peretz T,Nori D,Hilaris B,et al.Treatment of primary unresectable carcinoma of the pancreas with I-125 implantation.Int J Radiat Oncol Biol Phys,1989,17:931-935. 被引量：1
4Lebovics E,Mittelman A,Del Guercio LR,et al.Pancreaticobiliary fistula and obstructive jaundice complicating 125Ⅰ interstitial implants for pancreatic cancer:endoscopic diagnosis and management.Gastrointest Endosc,1990,36:610-611. 被引量：1
5Nori D,Merimsky O,Osian AD,et al.Palladium-103:a new radioactive source in the treatment of unresectable carcinoma of the pancreas:a phase Ⅰ-Ⅱ study.J Surg Oncol,1996,61:300-305. 被引量：1
6Mobiuddin M,Rosato F,Darbot D,et al.Long-term results of combined modality treatment with 125I inplantation for carcinoma of pancreas[J].Int J Radiat Oncol Bio Phys,1992,23(2):305-311. 被引量：1
7Parkin D M,Bray F I,Evesa S S.Cancer burden in the year 2000.The global picture[J].Cancer,2001,37(1):54-56. 被引量：1
8Coopman A M.Pancreatic cancer the bigger picture[J].Surg Clin North Am,2001,81(3):557-574. 被引量：1
9Willett C G,Safran H,Abrams R A,et al.Clinical research in pancreatic cancer:the Radiation Therapy Oncology Group trials[J].Int J Radiat Oncol Biol Phys,2003,56(4 Suppl):31-37. 被引量：1
10Moore M J.pancreatic cancer:what the oncologist can offer for palliation[J].Can J Gastroenterol,2002,16(2):121-124. 被引量：1
7Emerson RE, Ulbright TM. Intratubutar germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers. Pathology. 2010.42:344-355. 被引量：1
8Wray C J, Ahmad SA, Matthews JB, et al. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology, 2005, 128: 1626-1641. 被引量：1
9Hwang SS, Scott CB, Chang VT,et al. Prediction of survival for advanced cancer patients by reeursive partitioning analysis : role of Karnofsky performance status, quality of life, and symptom distress. Cancer Invest, 2004,22:678-687. 被引量：1
10EVANS DB, ABBRUZZESS JL, RICH TA. Cancer: principles and practice of oncology. Philadelphia: Lippincott-Raven Publishers, 1997 : 1054 -1087. 被引量：1
